Dr. Zirwas discusses clinical impacts of notable additions to the dermatology literature this year—including 1% diclofenac gel for acne keloidalis nuchae and pseudofolliculitis barbae and oral roflumilast for inflammatory dermatoses.

Dr. Oza discusses new methods for detecting preclinical AD in infants, new insights into early-onset AD predictive of future food allergies, and a variety of...
PLAY